{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:22:00Z","timestamp":1790277720858,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune polyendocrine syndromes (APS) is a rare group of disorders caused by impaired function of multiple endocrine glands due to disruption of immune tolerance. Of which, type 2 (APS-2) is the most common. Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme for the synthesis of gamma-aminobutyric acid (GABA). Anti-GAD antibodies are associated with various neurological disorders, including stiff person syndrome (SPS). SPS is characterized by axial muscle stiffness, rigidity, and intermittent painful muscle spasms, with a prevalence of one to two in a million, making it an extremely rare neurological disorder. The comorbidity of APS-2 with SPS is even rarer. Most practicing neurologists encounter only one or two cases of APS-2 combined with anti-GAD65 antibody-associated SPS in their careers, resulting in underdiagnosis and undertreatment, leading to severe disability and suffering. This case report describes a young male who initially exhibited hair loss, vitiligo, and previously unreported eosinophilia. Before his diagnosis, he was admitted multiple times, with symptoms improving following the addition of intravenous immunoglobulin (IVIG) therapy to a poor treatment regimen. This paper aims to increase physicians\u2019 awareness of this condition, enhancing the likelihood of early diagnosis and treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1471115","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:25:47Z","timestamp":1736227547000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The IVIG treatment response in autoimmune polyendocrine syndromes type 2 with anti-GAD65 antibody-associated stiff person syndrome: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Yulong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1172\/jci11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199005313222202","article-title":"Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome","volume":"322","author":"Solimena","year":"1990","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000123456","article-title":"Immunohistochemical studies of the GABA system in the pancreas","volume":"36","author":"Vincent","year":"1983","journal-title":"Neuroendocrinology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.024","article-title":"Humoral and cellular autoimmune responses in stiff person syndrome","volume":"998","author":"Lohmann","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/14734220309432","article-title":"Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies","volume":"2","author":"Vianello","year":"2003","journal-title":"Cerebellum"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.07.011","article-title":"GAD antibodies associated neurological disorders: incidence and phenotype distribution among neurological inflammatory diseases","volume":"227","author":"Mat\u00e0","year":"2010","journal-title":"J Neuroimmunol"},{"key":"B9","article-title":"Progressive fluctuating muscular rigidity and spasm (\u201cstiff-man\u201d syndrome); report of a case and some observations in 13 other cases","volume":"31","author":"Moersch","year":"1956","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01188-w","article-title":"Stiff-person syndrome and GAD antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies","volume":"19","author":"Dalakas","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.7759\/cureus.427","article-title":"Recent advances and review on treatment of stiff person syndrome in adults and pediatric patients","volume":"7","author":"Bhatti","year":"2015","journal-title":"Cureus"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2011-000071","article-title":"Stiff person syndrome","volume":"11","author":"Hadavi","year":"2011","journal-title":"Pract Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.65.12.1434","article-title":"Autoimmune polyglandular syndrome type 2","volume":"65","author":"Martins","year":"2019","journal-title":"Rev Assoc Med Bras 1992"},{"key":"B15","article-title":"Autoimmune polyglandular syndrome type 2 with alopecia universalis and hypoparathyroidism","volume":"63","author":"Dave","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1471-4159.1993.tb03165.x","article-title":"Regulation of gamma-aminobutyric acid synthesis in the brain","volume":"60","author":"Martin","year":"1993","journal-title":"J Neurochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb08211.x","article-title":"Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions","volume":"56","author":"Kaufman","year":"1991","journal-title":"J Neurochem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-d","article-title":"Two genes encode distinct glutamate decarboxylases","volume":"7","author":"Erlander","year":"1991","journal-title":"Neuron"},{"key":"B20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1570159x16666180917105033","article-title":"Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges","volume":"17","author":"Mitoma","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4065\/81.9.1207","article-title":"Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11940-017-0485-y","article-title":"Treatment of cerebellar ataxia in the context of systemic diseases","volume":"19","author":"Proudfoot","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-444-64189-2.00023-8","article-title":"Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia","volume":"155","author":"Manto","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.01.007","article-title":"Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus","volume":"317","author":"Nakajima","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e4738","DOI":"10.7759\/cureus.4738","article-title":"Neurological disorders associated with glutamic acid decarboxylase antibodies","volume":"11","author":"Herard","year":"2019","journal-title":"Cureus"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMc1805308","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Sepe","year":"2018","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/eje-09-0044","article-title":"Polyglandular autoimmune syndromes","volume":"161","author":"Kahaly","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.7.7636","article-title":"Clinical review 130: Addison\u2019s disease 2001","volume":"86","author":"Ten","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1035684","article-title":"Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation","volume":"124","author":"F\u00f6rster","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030158","article-title":"Autoimmune polyendocrine syndromes","volume":"350","author":"Eisenbarth","year":"2004","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51791","article-title":"Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria","volume":"10","author":"Chia","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.07.011","article-title":"Immunological GABAergic interactions and therapeutic applications in autoimmune diseases","volume":"14","author":"Prud\u2019homme","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1017\/s1047951120004308","article-title":"Low-dose steroid-induced bradyarrhythmias and treatment refractory hypokalaemia: a case report","volume":"31","author":"Ghosh","year":"2021","journal-title":"Cardiol Young"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1232-z","article-title":"Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder","volume":"19","author":"Rakocevic","year":"2019","journal-title":"BMC Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309201","article-title":"Stiff-person syndrome: insights into a complex autoimmune disorder","volume":"86","author":"Baizabal-Carvallo","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with stiff-person spectrum disorder","volume":"73","author":"Martinez-Hernandez","year":"2016","journal-title":"JAMA Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-1105-4","article-title":"The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies","author":"Dalakas","year":"2005","journal-title":"J Neurol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211003486","article-title":"GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions","volume":"14","author":"Tsiortou","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e200011","DOI":"10.1212\/NXI.0000000000200011","article-title":"Long-term effectiveness of IVIg maintenance therapy in 36 patients with GAD antibody-positive stiff-person syndrome","volume":"9","author":"Yi","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577915","article-title":"Stiff person syndrome spectrum disorders; more than meets the eye","volume":"369","author":"Newsome","year":"2022","journal-title":"J Neuroimmunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-266X.2021.36.015","article-title":"Diagnosis and treatment of stiff person syndrome (with analysis of 15 cases)","volume":"61","author":"Ji","year":"2021","journal-title":"Shandong Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-0152.2016.09.014","article-title":"Zhuang J.Progress in the study of the stiff person syndrome","volume":"42","author":"Li","year":"2016","journal-title":"Chin J Nervous Ment Diseases"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"Dalakas","year":"2001","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25002","article-title":"placebo-controlled study of rituximab in patients with stiff person syndrome","volume":"82","author":"Dalakas","year":"2017","journal-title":"Ann Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1586\/1744666x.2013.845527","article-title":"Immunology of stiff person syndrome and other GAD-associated neurological disorders","volume":"9","author":"Alexopoulos","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000011338","article-title":"Autologous hematopoietic stem cell transplantation for stiff-person spectrum disorder: A clinical trial","volume":"96","author":"Burt","year":"2021","journal-title":"Neurology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11970-1","article-title":"Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome","volume":"271","author":"Di Stefano","year":"2024","journal-title":"J Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1471115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:25:52Z","timestamp":1736227552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1471115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2024.1471115"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1471115","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1471115"}}